Fic1 is expressed at apical membranes of different epithelial cells in the digestive tract and is induced in the small intestine during postnatal development of mice

Pediatric Research

Volumn 56, Issue 6, 2004, Pages 981-987

  Van Mil, Saskia W C ^a   Van Oort, Masja M ^a   Van Den Berg, Inge E T ^a   Berger, Ruud ^a   Houwen, Roderick H J ^a   Klomp, Leo W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN FIC1; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CHOLESTASIS; CONTROLLED STUDY; DIGESTIVE SYSTEM; EPITHELIUM CELL; GENE EXPRESSION; GENE LOCATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; LIVER CELL; MATURATION; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BILE DUCTS; CELL POLARITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTESTINAL MUCOSA; INTESTINES; LIVER; MICE; MICE, INBRED C57BL; PANCREAS; STOMACH;

EID: 9244263543     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000145564.06791.D1     Document Type: Article

References (50)

1. Muller M, Jansen PL 1998 The secretory function of the liver: new aspects of hepatobiliary transport. J Hepatol 28:344-354
2. Trauner M, Meier PJ, Boyer JL 1998 Molecular pathogenesis of cholestasis. N Engl J Med 339:1217-1227
3. Elferink RO. Groen AK 2002 Genetic defects in hepatobiliary transport. Biochim Biophys Acta 1586:129-145
4. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, Klomp LW, Lomri N, Berger R, Scharschmidt BF, Knisely AS, Houwen RH, Freimer NB 1998 A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18:219-224
5. van Mil SW, Klomp LW, Bull LN, Houwen RH 2001 FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 21:535-544
6. Bijleveld CM, Vonk RJ, Kuipers F, Havinga R, Boverhof R, Koopman BJ, Wolthers BG, Fernandes J 1989 Benign recurrent intrahepatic cholestasis: altered bile acid metabolism. Gastroenterology 97:427-432
7. De Koning TJ, Sandkuijl LA, De Schryver JE, Hennekam EA, Beemer FA, Houwen RH 1995 Autosomal-recessive inheritance of benign recurrent intrahepatic cholestasis. Am J Med Genet 57:479-482
8. Summerskill WH, Walshe JM 1959 Benign recurrent intrahepatic obstructive jaundice. Lancet 2:686-690
9. Bull LN, Carlton VE, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, Magid MS, Kahn E, Markowitz J, DiCarlo FJ, McLoughlin L, Boyle JT, Dahms BB, Faught PR, Fitzgerald JF, Piccoli DA, Witzleben CL, O'Connell NC, Setchell KD, Agostini RM Jr, Kocoshis SA, Reyes J, Knisely AS 1997 Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 26:155-164
10. Clayton RJ, Iber FL, Ruebner BH, McKusick VA 1969 Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 117:112-124
11. Linarelli LG, Williams CN, Phillips MJ 1972 Byler's disease: fatal intrahepatic cholestasis. J Pediatr 81:484-492
12. Klomp LW, Bull LN, Knisely AS, van Der Doelen MA, Juijn JA, Berger R, Forget S, Nielsen IM, Eiberg H, Houwen RH 2000 A missense mutation in FIC1 is associated with Greenland familial cholestasis. Hepatology 32:1337-1341
13. Mouro I, Halleck MS, Schlegel RA, Mattel MG, Williamson P, Zachowski A, Devaux P. Cartron JP, Colin Y 1999 Cloning, expression, and chromosomal mapping of a human ATPase II gene, member of the third subfamily of P-type ATPases and orthologous to the presumed bovine and murine aminophospholipid translocase. Biochem Biophys Res Commun 257:333-339
14. Tang X, Halleck MS, Schlegel RA, Williamson P 1996 A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272:1495-1497
15. Siegmund A, Grant A, Angeletti C, Malone L, Nichols JW, Rudolph HK 1998 Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J Biol Chem 273:34399-34405
16. Ujhazy P, Ortiz D, Misra S, Li S, Moseley J, Jones H, Arias IM 2001 Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 34:768-775
17. Eppens EF, van Mil SW, de Vree JM, Mok KS, Juijn JA, Oude Elferink RP, Berger R, Houwen RH, Klomp LW 2001 FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 35:436-443
18. Bhagat G, Lobritto SJ, Lefkowitch JH, Bourke B, Mc Dermott M, Portmann BC 2001 Allograft steatosis is a feature of progressive familial intrahepatic cholestasis type 1 (FIC1 disease), treated by orthopic liver transplantation (OLTX). Hepatology 34:209A
19. Coleman R, Iqbal S, Godfrey PP, Billington D 1979 Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties. Biochem J 178:201-208
20. Lykavieris P, van Mil S, Cresteil D, Fabre M, Hadchouel M, Klomp L, Bernard O, Jacquemin E 2003 Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 39:447-452
21. van Ooteghem NA, Klomp LW, van Berge-Henegouwen GP, Houwen RH 2002 Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol 36:439-443
22. Pawlikowska L, Groen A, Eppens EF, Kunne C, Ottenhoff R, Looije N, Knisely AS, Killeen NP, Bull LN, Elferink RP, Freimer NB 2004 A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 13:881-892
23. Suchy FJ, Bucuvalas JC, Novak DA 1987 Determinants of bile formation during development: ontogeny of hepatic bile acid metabolism and transport. Semin Liver Dis 7:77-84
24. Klomp AE, Tops BB, Van Denberg IE, Berger R, Klomp LW 2002 Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). Biochem J 364:497-505
25. Klomp AE, van de Sluis B, Klomp LW, Wijmenga C 2003 The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. J Hepatol 39:703-709
26. Vredendaal PJ, van den Berg IE, Malingre HE, Stroobants AK, Olde Weghuis DE, Berger R 1996 Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun 223:718-723
27. Heubi JE, Fondacaro JD 1982 Postnatal development of intestinal bile salt transport in the guinea pig. Am J Physiol 243:G189-G194
28. Hwang ST, Henning SJ 2000 Hormonal regulation of expression of ileal bile acid binding protein in suckling rats. Am J Physiol Regul Integr Comp Physiol 278:R1555-R1563
29. Chen CY, Ingram MF, Rosal PH, Graham TR 1999 Role for Drs2p, a P-type ATPase and potential aminophospholipid translocase, in yeast late Golgi function. J Cell Biol 147:1223-1236
30. Hua Z, Fatheddin P, Graham TR 2002 An essential subfamily of Drs2p-related P-type ATPases is required for protein trafficking between Golgi complex and endosomal/vacuolar system. Mol Biol Cell 13:3162-3177
31. Pomorski T, Lombardi R, Riezman H, Devaux PF, van Meer G, Holthuis JC 2003 Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis. Mol Biol Cell 14:1240-1254
32. Halleck MS, Lawler JF Jr, Blackshaw S, Gao L, Nagarajan P, Hacker C, Pyle S, Newman JT, Nakanishi Y, Ando H, Weinstock D, Williamson P, Schlegel RA 1999 Differential expression of putative transbilayer amphipath transporters. Physiol Genomics 1:139-150
33. Egawa H, Yorifuji T, Sumazaki R, Kimura A, Hasegawa M, Tanaka K 2002 Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin. Liver Transpl 8:714-716
34. Knisely AS, Boyle JT, Naylor EW, Klinger K, Freimer N, Kocoshis SA 1995 Pancreatic disfunction in Byler disease. J Pediatr Gastroenterol Nutr 21:328(abstr)
35. Knisely AS 2000 Progressive familial intrahepatic cholestasis: a personal perspective. Pediatr Dev Pathol 3:113-125
36. Tygstrup N 1960 Intermittent possibly intrahepatic cholestatic jaundice. Lancet 1:1171-1172
37. Tygstrup N, Steig BA, Juijn JA, Bull LN, Houwen RH 1999 Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology 29:506-508
38. Little JM, Lester R 1980 Ontogenesis of intestinal bile salt absorption in the neonatal rat. Am J Physiol 239:G319-G323
39. Stahl GE, Mascarenhas MR, Payer JC, Shiau YF, Watkins JB 1993 Passive jejunal bile salt absorption alters the enterohepatic circulation in immature rats. Gastroenterology 104:163-173
40. Shneider BL, Dawson PA, Christie DM, Hardikar W, Wong MH, Suchy FJ 1995 Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest 95:745-754
41. Jung D, Fried M, Kullak-Ublick GA 2002 Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J Biol Chem 277:30559-30566
42. Hwang ST, Urizar NL, Moore DD, Henning SJ 2002 Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 122:1483-1492
43. Hwang ST, Urizar NL, Moore DD, Henning SJ 2002 Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 122:1483-1492
44. Christie DM, Dawson PA, Thevananther S, Shneider BL 1996 Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. Am J Physiol 271:G377-G385
45. Pawlikowska L, Ottenhoff R, Looije N, Eppens EF, Knisely AS, Bull LN, Oude Elferink RP 2001 FIC1 mutant mice have a defect in the regulation of intestinal bile acid absorption. Hepatology 34:240A
46. Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, Zatloukal K, Trauner M 2001 Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33:633-646
47. Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, Shan B, Schwarz M, Kuipers F 2003 Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 278:41930-41937
48. Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL 2004 Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126:756-764
49. de Belle RC, Vaupshas V, Vitullo BB, Haber LR, Shaffer E, Mackie GG, Owen H, Little JM, Lester R 1979 Intestinal absorption of bile salts: immature development in the neonate. J Pediatr 94:472-476
50. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL 1994 Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 18:134-141